You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

~ Buy the BESIVANCE (besifloxacin hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR BESIVANCE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for BESIVANCE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00347932 ↗	A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.	Completed	Bausch & Lomb Incorporated	Phase 3	2006-06-01	Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.
NCT00824070 ↗	Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects	Completed	Bausch & Lomb Incorporated	Phase 1	2009-02-01	This study is being conducted to assess the concentration of besifloxacin, moxifloxacin, or gatifloxacin in aqueous humor samples collected following topical instillation of the associated formulation in subjects undergoing cataract surgery.
NCT00905762 ↗	Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation	Completed	Bausch & Lomb Incorporated	Phase 1	2009-03-01	The purpose of this study is to assess the concentration of besifloxacin compared to gatifloxacin and moxifloxacin in human conjunctival tissue, following a single drop of the drug instilled topically into the study eye. Conjunctival biopsies will be performed at specified time points, followed by the use of loteprednol etabonate/tobramycin ophthalmic suspension four times a day for 5 days.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for BESIVANCE

Condition Name

Chart
Table

Condition Name for BESIVANCE
Intervention	Trials
Bacterial Conjunctivitis	4
Cataract Extraction	2
Cataract Surgery	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for BESIVANCE
Intervention	Trials
Conjunctivitis, Bacterial	5
Conjunctivitis	5
Cataract	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for BESIVANCE

Trials by Country

Map
Table

Trials by Country for BESIVANCE
Location	Trials
United States	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for BESIVANCE
Location	Trials
New York	6
New Jersey	2
Pennsylvania	1
Maryland	1
Kentucky	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for BESIVANCE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for BESIVANCE
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	4
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for BESIVANCE
Clinical Trial Phase	Trials
Completed	10
Terminated	2
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BESIVANCE

Sponsor Name

Chart
Table

Sponsor Name for BESIVANCE
Sponsor	Trials
Bausch & Lomb Incorporated	10
Rutgers, The State University of New Jersey	1
Ophthalmology Associates, St Louis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for BESIVANCE
Sponsor	Trials
Industry	12
Other	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.